logo
Sign in

Biolinq Incorporated

SAN DIEGO, CA · Founded 2012 · Medtech · Private

Needle-free glucose sensor that integrates glucose monitoring with activity and sleep tracking

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · biolinq.com

Sector
Medtech
Headquarters
SAN DIEGO, CA
Founded
2012
Latest Form D
$90M, Mar 2025
Total capital
$214M
Federal grants
$6.3M
11 awards · 2015–2026
Rank in peer group#108 of 538
Private capital raised
$208M
8 Form D · last Mar 2025
19 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
27
13 pending · first 2024
Rank in peer group#9 of 538

Capital timeline

201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $214M$996K$500K$799K$786K$854K$862K6th Form D$62.2M8th Form D$90M
201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $214M$996K$799K$854K$862K

Latest events

  • Federal grantHealth and Human S · Phase II · Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes$862K
  • Federal grantHealth and Human S · Phase II · Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes$854K
  • Private capital raisedForm D · SEC · 8th filing$90M
  • Private capital raisedForm D · SEC · 7th filing$35.1M
  • Federal grantHealth and Human S · Phase II · A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability$786K
  • Federal grantHealth and Human S · Phase II · A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability$799K
  • Private capital raisedForm D · SEC · 6th filing$62.2M
  • Private capital raisedForm D · SEC · 5th filing$5.2M
  • Private capital raisedForm D · SEC · 4th filing$3.6M
  • Private capital raisedForm D · SEC · 3rd filing$3M
  • Private capital raisedForm D · SEC · 2nd filing$8.1M
  • Private capital raisedForm D · SEC · 1st filing$450K
Show 7 earlier federal awards
  • Federal grantHealth and Human S · Phase II · A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability$299K
  • Federal grantHealth and Human S · Phase II · Wearable Biosensors for Real-time Blood Alcohol Monitoring$500K
  • Federal grantHealth and Human S · Phase II · Wearable Biosensors for Real time Blood Alcohol Monitoring$996K
  • Federal grantHealth and Human S · Phase II · Wearable Biosensors for Real-time Blood Alcohol Monitoring$496K
  • Federal grantHealth and Human S · Phase II · Wearable Biosensors for Real-time Blood Alcohol Monitoring$182K
  • Federal grantHealth and Human S · Phase I · Microneedle-based Transdermal Sensing of Electrolytes: Towards A Metabolic Panel-$300K
  • Federal grantHealth and Human S · Phase I · Non-invasive Continuous Hydration Monitoring$181K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

15months

from Biolinq Incorporated’s first federal award to its first private round.

First federal award · Jun 2015
Health and Human S · $181K
First Form D · Sep 2016
$450K · 1st Form D
Awards before first raise
5 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#108 · top 20%
  • Granted patents#9 · top 2%
  • Linked publications#49 · top 9%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Joshua WindmillerResearcherExecutive Officer, Director, PromoterLinked by 2 patents · $996K in grants as PI
  • CHRIS DIMITROPOULOSDirectorNamed in SEC Form D filings
  • DAN BRADBURYDirectorNamed in SEC Form D filings
  • Daniel BradburyDirectorNamed in SEC Form D filings
  • DAVID ARIDAExecutive OfficerNamed in SEC Form D filings
  • DAVID AFFAS BERRYDirectorNamed in SEC Form D filings
Show all 14 people
  • DEREK RAPPDirectorNamed in SEC Form D filings
  • Edward KliphuisDirectorNamed in SEC Form D filings
  • Jared TangneyExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Lana GhanemDirectorNamed in SEC Form D filings
  • Nancy HongDirectorNamed in SEC Form D filings
  • RICHARD YANGExecutive Officer, DirectorNamed in SEC Form D filings
  • THAD JOHNSONDirectorNamed in SEC Form D filings
  • ZINA AFFAS BESSEDirectorNamed in SEC Form D filings

What it has protected

USPTO · 27 granted of 40
Show all 40 patent records

Recent research by its founders

  • 69-LB: A Wearable Microneedle Array Sensor Shows High Correlation between Dermal Glucose and Venous Blood Glucose20202 cites
  • Musings of a Protégé20180 cites
  • Continuous minimally-invasive alcohol monitoring using microneedle sensor arrays2017274 cites

Related companies, and why

  • Nine Continents Medical IncSimilar federal contract value in Medtech · null in contracts
  • Eysz, Inc.Similar federal contract value in Medtech · null in contracts
  • VELLUM BIOSCIENCES LLCSimilar federal contract value in Medtech · null in contracts
  • Apex Cool Labs, Inc.Similar federal contract value in Medtech · null in contracts
  • ANXOMICS LLCSimilar federal contract value in Medtech · null in contracts
  • PinkDx, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .